Sorafenib-sunitinib sequence: The jury is out

Laurence Albiges; Bernard Escudier

doi:10.1016/j.eururo.2015.06.050

Sorafenib-sunitinib sequence: The jury is out

Laurence Albiges, Bernard Escudier

Research output: Contribution to journal › Editorial

2 Citations (Scopus)

Original language	English
Pages (from-to)	848-849
Number of pages	2
Journal	European Urology
Volume	68
Issue number	5
DOIs	https://doi.org/10.1016/j.eururo.2015.06.050
Publication status	Published - 1 Nov 2015

Access to Document

10.1016/j.eururo.2015.06.050

Cite this

@article{882b0c47d002420fb78038aa5a27fe7d,

title = "Sorafenib-sunitinib sequence: The jury is out",

author = "Laurence Albiges and Bernard Escudier",

note = "Funding Information: Laurence Albiges has a consulting or advisory role with Pfizer, Novartis, Sanofi, and Amgen and receives research funding from Pfizer and Novartis. Bernard Escudier has a consulting or advisory role with Bayer, Pfizer, and Novartis and has received honoraria from Bayer AG, Roche, Pfizer, Genentech, Novartis, AVEO Pharmaceuticals, and GlaxoSmithKline.",

year = "2015",

month = nov,

day = "1",

doi = "10.1016/j.eururo.2015.06.050",

language = "English",

volume = "68",

pages = "848--849",

journal = "European Urology",

issn = "0302-2838",

number = "5",

}

TY - JOUR

T1 - Sorafenib-sunitinib sequence

T2 - The jury is out

AU - Albiges, Laurence

AU - Escudier, Bernard

N1 - Funding Information: Laurence Albiges has a consulting or advisory role with Pfizer, Novartis, Sanofi, and Amgen and receives research funding from Pfizer and Novartis. Bernard Escudier has a consulting or advisory role with Bayer, Pfizer, and Novartis and has received honoraria from Bayer AG, Roche, Pfizer, Genentech, Novartis, AVEO Pharmaceuticals, and GlaxoSmithKline.

PY - 2015/11/1

Y1 - 2015/11/1

UR - http://www.scopus.com/inward/record.url?scp=84942991663&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2015.06.050

DO - 10.1016/j.eururo.2015.06.050

M3 - Editorial

C2 - 26184972

AN - SCOPUS:84942991663

SN - 0302-2838

VL - 68

SP - 848

EP - 849

JO - European Urology

JF - European Urology

IS - 5

ER -

Sorafenib-sunitinib sequence: The jury is out

Access to Document

Other files and links

Cite this